The week in review

We take a look at the last week in pharmacy

This week, the headlines were all about medicines themselves. Researchers from The George Institute announced findings that NSAIDs aren’t effective in back pain, prompting ASMI to put out a statement saying they’re still suitable in acute pain.

Western Australia implemented new measures to curb “doctor shopping” and self-harm caused by inappropriate use of controlled drugs – a move the Guild says it strongly supports.

Rescheduling, or in some cases potential rescheduling, has been a focus. A new alternative for women seeking emergency contraception became Pharmacist Only, and ACMS recommending changes to the scheduling of once-weekly vitamin D and paracetamol compounded with caffeine.

And the TGA announced that one application to reschedule a drug was denied: nicotine for the purpose of harm reduction in smoking.

There’s strong demand for libido-enhancing medicines for women. And there’s also demand for better information about how medicines can affect alertness.

Meanwhile, access to prescription medicine at all remains a problem for 1.8 million Australians, the Productivity Commission has found. And that’s not even mentioning patients affected by ongoing medicines shortages.



Previous What’s Trending: Technology in Pharmacy
Next Meet the finalists: Beaufort St 24hr Chemist

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply